GO:0035932 aldosterone secretion: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035932 aldosterone secretion describes the regulated release of aldosterone, a pregnane-based steroid hormone, into the circulatory system.
• Aldosterone is produced by the zona glomerulosa of the adrenal cortex and acts on distal tubules and collecting ducts to conserve sodium, secrete potassium, retain water, and raise blood pressure.
• The renin-angiotensin-aldosterone system (RAAS) is the principal regulator of aldosterone secretion, and its alterations are central to hypertension and cardiovascular disease.
• Ion channels, including calcium and potassium channels, control basal aldosterone secretion and are implicated in primary aldosteronism.
• Autonomous aldosterone secretion represents a subclinical form of primary aldosteronism with significant clinical implications.
• Cyclical aldosterone secretion patterns can be modeled mathematically to improve diagnostic insights in primary hyperaldosteronism.
Description
Aldosterone secretion (GO:0035932) is the biological process by which the steroid hormone aldosterone is released into the circulatory system. Aldosterone is a pregnane-based steroid hormone synthesized in the zona glomerulosa of the adrenal cortex, and its release is tightly regulated to maintain electrolyte and fluid balance. This process is essential for normal physiology, as aldosterone acts on the distal tubules and collecting ducts of the kidney to promote sodium reabsorption, potassium secretion, water retention, and ultimately increased blood pressure. Dysregulation of aldosterone secretion is a key mechanism in hypertension, primary aldosteronism, and related cardiovascular disorders. Researchers study aldosterone secretion to understand how ion channels, signaling pathways, and genetic factors contribute to both basal secretion and pathological states such as autonomous aldosterone production. Recent work has also focused on predicting unilateral aldosterone secretion in primary aldosteronism and on mathematical modeling of cyclical secretion patterns to improve diagnosis. Understanding the molecular and cellular basis of aldosterone secretion is therefore critical for developing targeted therapies and diagnostic tools.
aldosterone secretion At A Glance
| GO ID | GO:0035932 |
|---|---|
| GO term | aldosterone secretion |
| Ontology | biological_process |
| Synonym | None |
| Major function | Regulated release of aldosterone into the circulatory system to maintain sodium and potassium balance, water retention, and blood pressure |
| Site of production | Zona glomerulosa of the adrenal cortex |
| Primary target | Distal tubules and collecting ducts of the kidney |
| Key regulator | Renin-angiotensin-aldosterone system (RAAS) |
| Pathological relevance | Primary aldosteronism, hypertension, and cardiovascular disease |
What Is GO:0035932?
GO:0035932 aldosterone secretion is defined as the regulated release of aldosterone into the circulatory system. Aldosterone is a pregnane-based steroid hormone produced by the outer section (zona glomerulosa) of the adrenal cortex in the adrenal gland. It acts on the distal tubules and collecting ducts of the kidney to cause conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.
Why Is aldosterone secretion Important in Cell Biology?
Aldosterone secretion is a fundamental physiological process that controls electrolyte homeostasis and blood pressure, and its dysregulation is directly linked to major human diseases including primary aldosteronism, hypertension, and heart failure. Understanding the mechanisms that govern aldosterone release is essential for diagnosing and treating these conditions, as well as for interpreting the effects of therapeutic interventions that target the RAAS. Moreover, research into ion channels and signaling pathways that regulate aldosterone secretion has revealed new targets for pharmacological modulation and has advanced the understanding of autonomous aldosterone production in adrenal disorders.
• Maintains sodium and potassium balance and extracellular fluid volume through renal action.
• Regulates blood pressure as part of the renin-angiotensin-aldosterone system.
• Dysregulation causes primary aldosteronism, a common cause of secondary hypertension.
• Autonomous aldosterone secretion can occur as a subclinical form of primary aldosteronism.
• Ion channels are critical regulators of basal aldosterone secretion and are implicated in primary aldosteronism.
• Predicting unilateral aldosterone secretion is important for surgical decision-making in primary aldosteronism.
• Cyclical aldosterone secretion patterns may affect diagnostic accuracy in primary hyperaldosteronism.
• Aldosterone-producing adenomas can influence insulin secretion and sensitivity, linking aldosterone to metabolic outcomes.
• Disorders of aldosterone secretion in childhood have distinct clinical presentations and require specialized management.
• Mast cell deficiency can lead to dysregulation of aldosterone secretion in mouse models, suggesting immune-endocrine interactions.
What Happens During aldosterone secretion?
Stimulation by Angiotensin II and Potassium
In simple terms: The process starts when the body signals that sodium is low or potassium is high, triggering the release of hormones that tell the adrenal gland to make aldosterone.
Aldosterone secretion is primarily stimulated by angiotensin II and elevated extracellular potassium levels. The renin-angiotensin-aldosterone system (RAAS) responds to reduced renal perfusion, low sodium, or sympathetic activation by increasing renin release, which ultimately leads to angiotensin II production. Angiotensin II binds to AT1 receptors on zona glomerulosa cells, activating phospholipase C and increasing intracellular calcium, which promotes aldosterone synthesis and secretion. Potassium directly depolarizes zona glomerulosa cells, opening voltage-gated calcium channels and stimulating aldosterone production.
Calcium Signaling and Ion Channel Regulation
In simple terms: Calcium acts as a switch inside adrenal cells, and ion channels control how much calcium enters, which determines how much aldosterone is released.
Calcium influx through T-type and L-type calcium channels is a key trigger for aldosterone secretion. Ion channels, including potassium channels such as TASK and calcium-activated potassium channels, modulate the membrane potential of zona glomerulosa cells and thereby regulate calcium entry. Mutations in these channels can lead to autonomous aldosterone secretion, as seen in primary aldosteronism. The interplay between potassium conductance, membrane depolarization, and calcium signaling is therefore central to both basal and stimulated aldosterone release.
Steroidogenic Enzyme Activation and Aldosterone Synthesis
In simple terms: Once the cell receives the signal, a series of enzymes convert cholesterol into aldosterone, which is then ready to be released.
Aldosterone synthesis requires the sequential action of steroidogenic enzymes, including CYP11B2 (aldosterone synthase), which catalyzes the final steps of conversion from deoxycorticosterone to aldosterone. The expression of CYP11B2 is regulated by angiotensin II and potassium, and its activity determines the rate of aldosterone production. Cholesterol is transported into mitochondria by the steroidogenic acute regulatory protein (StAR), where CYP11B2 and other enzymes act. The newly synthesized aldosterone is then secreted into the circulation.
Secretion into the Circulation
In simple terms: After aldosterone is made, it leaves the adrenal cell and enters the bloodstream to travel to the kidneys.
Aldosterone is a lipophilic steroid hormone and diffuses across the plasma membrane into the interstitial fluid and then into the bloodstream. The regulated release of aldosterone into the circulatory system is the defining event of GO:0035932. Once in the circulation, aldosterone binds to mineralocorticoid receptors in target tissues, particularly the distal tubules and collecting ducts of the kidney, to exert its effects on sodium reabsorption, potassium secretion, and water retention.
Feedback Regulation and Cyclical Patterns
In simple terms: The body continuously adjusts aldosterone levels based on sodium and potassium status, and these levels can follow daily or cyclical patterns.
Aldosterone secretion is subject to negative feedback: increased sodium reabsorption and volume expansion suppress renin release, reducing angiotensin II and aldosterone production. Conversely, hyperkalemia directly stimulates aldosterone secretion. Recent mathematical modeling has revealed cyclical patterns in aldosterone secretion that may influence diagnostic testing for primary hyperaldosteronism. These dynamic fluctuations highlight the importance of timing in clinical assessments of aldosterone secretion.
Key Genes Involved in GO:0035932 aldosterone secretion
The following genes and proteins are central to the regulation and execution of aldosterone secretion, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| REN | Encodes renin, the rate-limiting enzyme in the RAAS that initiates angiotensin II production | Key regulator of aldosterone secretion; alterations linked to hypertension |
| AGT | Encodes angiotensinogen, the substrate for renin | Genetic variants influence RAAS activity and aldosterone levels |
| ACE | Encodes angiotensin-converting enzyme, which generates angiotensin II | Target of ACE inhibitors; affects aldosterone secretion |
| AGTR1 | Encodes the angiotensin II receptor type 1, mediating aldosterone stimulation | Mutations or polymorphisms impact aldosterone production |
| CYP11B2 | Encodes aldosterone synthase, the final enzyme in aldosterone synthesis | Mutations cause familial hyperaldosteronism; target for primary aldosteronism research |
| STAR | Encodes steroidogenic acute regulatory protein, transporting cholesterol into mitochondria | Essential for steroidogenesis; regulates aldosterone synthesis capacity |
| KCNJ5 | Encodes a potassium channel (GIRK4) involved in membrane potential regulation | Mutations cause autonomous aldosterone secretion in aldosterone-producing adenomas |
| CACNA1D | Encodes a voltage-gated calcium channel (Cav1.3) in zona glomerulosa cells | Mutations lead to increased calcium influx and aldosterone production |
| ATP1A1 | Encodes Na+/K+-ATPase alpha-1 subunit | Mutations alter ion homeostasis and stimulate aldosterone secretion |
| ATP2B3 | Encodes a plasma membrane calcium ATPase | Mutations affect calcium handling and aldosterone secretion |
| CTNNB1 | Encodes beta-catenin, involved in Wnt signaling | Mutations found in aldosterone-producing adenomas |
| MC2R | Encodes melanocortin 2 receptor (ACTH receptor) | ACTH can stimulate aldosterone secretion under certain conditions |
| NR4A1 | Encodes nuclear receptor Nur77, involved in steroidogenic gene regulation | May modulate aldosterone synthesis in response to angiotensin II |
| NR4A2 | Encodes nuclear receptor Nurr1, implicated in steroidogenesis | Potential regulator of aldosterone production |
| POMC | Encodes pro-opiomelanocortin, precursor to ACTH | ACTH can influence aldosterone secretion |
| KCNK3 | Encodes TASK-1 potassium channel | Regulates membrane potential and aldosterone secretion |
| KCNK9 | Encodes TASK-3 potassium channel | Contributes to potassium conductance in zona glomerulosa cells |
How Is aldosterone secretion Regulated?
Aldosterone secretion is primarily regulated by the renin-angiotensin-aldosterone system (RAAS), which responds to changes in renal perfusion, sodium balance, and sympathetic tone. Angiotensin II and potassium are the major direct stimulators of aldosterone synthesis and release, acting through calcium-dependent signaling pathways in zona glomerulosa cells. Ion channels, including potassium and calcium channels, play a critical role in setting the resting membrane potential and controlling calcium influx, thereby modulating basal and stimulated aldosterone secretion. Additionally, ACTH from the pituitary can acutely stimulate aldosterone secretion, although its role in chronic regulation is less prominent. Negative feedback by sodium and volume status suppresses renin release, reducing aldosterone production. Recent studies have also highlighted cyclical patterns in aldosterone secretion that may affect diagnostic testing.
aldosterone secretion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNJ5 | Primary aldosteronism with autonomous aldosterone secretion | Knock-in of KCNJ5 mutation in adrenal cell line or mouse model |
| CACNA1D | Primary aldosteronism, calcium channelopathy | Point mutation knock-in in zona glomerulosa cells |
| ATP1A1 | Primary aldosteronism, ion pump dysfunction | Knockout or point mutation in adrenal cells |
| CYP11B2 | Familial hyperaldosteronism, aldosterone synthase dysregulation | Overexpression or knockout in H295R cells |
| MC2R | ACTH-dependent aldosterone secretion disorders | Knockout mouse model to study ACTH regulation |
Primary Aldosteronism
Primary aldosteronism is characterized by autonomous aldosterone secretion, leading to hypertension, hypokalemia, and cardiovascular damage. It is often caused by aldosterone-producing adenomas or bilateral adrenal hyperplasia, and mutations in ion channels such as KCNJ5, CACNA1D, ATP1A1, and ATP2B3 are frequently implicated. Autonomous aldosterone secretion can also occur in subclinical forms, making diagnosis challenging. Predicting unilateral versus bilateral aldosterone secretion is critical for determining surgical candidacy.
Hypertension and Cardiovascular Disease
Alterations in the RAAS, including excessive aldosterone secretion, contribute to the pathogenesis of hypertension and cardiovascular remodeling. Aldosterone promotes sodium retention and increases blood pressure, and its excess is associated with increased risk of stroke, heart failure, and myocardial fibrosis. Therapeutic strategies often target the RAAS to reduce aldosterone effects.
Metabolic and Endocrine Interactions
Aldosterone-producing adenomas can affect glucose metabolism and insulin sensitivity, as surgical treatment for primary aldosteronism has been shown to improve insulin secretion and sensitivity. Disorders of aldosterone secretion in childhood present unique diagnostic and management challenges, including salt-wasting crises and hypertension. Additionally, mast cell-deficient mice exhibit dysregulation of aldosterone secretion, suggesting a role for the immune system in modulating adrenal steroidogenesis.
From aldosterone secretion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate basal aldosterone secretion? | Knockout of the gene in H295R or primary adrenal cells |
| Does a specific mutation cause autonomous aldosterone production? | Point mutation knock-in (e.g., KCNJ5, CACNA1D) in adrenal cell lines |
| How does a risk variant affect aldosterone synthase expression? | Knock-in of the variant into the CYP11B2 locus in H295R cells |
| Where is the candidate protein localized in zona glomerulosa cells? | Tagged knock-in (e.g., GFP) in adrenal cell models |
| Does overexpression of a gene increase aldosterone secretion? | Overexpression of the gene in H295R cells or mouse adrenal glands |
| What is the effect of a gene on aldosterone secretion in vivo? | Adrenal-specific knockout or transgenic mouse models |
How to Study the aldosterone secretion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Aldosterone concentration in supernatant or plasma | Quantifying basal and stimulated secretion |
| Radioimmunoassay | Aldosterone levels with high sensitivity | Clinical and research measurement of aldosterone |
| Patch-clamp electrophysiology | Ion channel activity and membrane potential | Studying KCNJ5, CACNA1D mutations |
| Calcium imaging | Intracellular calcium transients | Assessing calcium signaling in zona glomerulosa cells |
| RNA-seq | Global gene expression changes | Identifying regulators of aldosterone secretion |
| Proteomics | Protein abundance and modifications | Discovering novel steroidogenic pathway components |
| Mathematical modeling | Predicted aldosterone secretion dynamics | Optimizing diagnostic testing for primary aldosteronism |
| In vivo microdialysis | Local aldosterone levels in tissues | Studying adrenal steroidogenesis in animal models |
Measuring Aldosterone Secretion
Aldosterone secretion is commonly measured using enzyme-linked immunosorbent assays (ELISA) or radioimmunoassays on cell culture supernatants or plasma samples. These methods quantify the amount of aldosterone released into the medium or circulation, allowing researchers to assess basal and stimulated secretion. For in vivo studies, aldosterone levels can be measured in serum or urine, often in combination with renin and angiotensin II measurements to evaluate RAAS activity.
Ion Channel and Calcium Imaging
Patch-clamp electrophysiology and calcium imaging are used to study ion channel activity and intracellular calcium dynamics in zona glomerulosa cells. These techniques help determine how mutations in potassium or calcium channels affect membrane potential and calcium influx, which are critical for aldosterone secretion. Fluorescent calcium indicators such as Fura-2 or Fluo-4 are commonly employed to monitor real-time changes in cytosolic calcium.
Transcriptomic and Proteomic Profiling
RNA sequencing (RNA-seq) and quantitative proteomics can identify genes and proteins differentially expressed under conditions that stimulate or suppress aldosterone secretion. These approaches reveal novel regulators and pathways involved in steroidogenesis. For example, RNA-seq of aldosterone-producing adenomas has uncovered somatic mutations and altered gene expression profiles.
Mathematical Modeling and Diagnostic Testing
Mathematical models of aldosterone secretion have been developed to simulate cyclical patterns and improve diagnostic protocols for primary hyperaldosteronism. These models integrate known physiological parameters to predict aldosterone dynamics and can inform the timing of clinical tests. Such approaches complement experimental studies by providing a systems-level understanding of secretion patterns.
How CRISPR Can Be Used to Study GO:0035932 aldosterone secretion
Knockout
CRISPR knockout is used to delete candidate genes in adrenal cell lines such as H295R to determine their necessity for aldosterone secretion. For example, knocking out KCNJ5 or CACNA1D can reveal whether these channels are required for basal or stimulated aldosterone production. Knockout models help establish causal roles of genes in the secretion pathway and can be combined with rescue experiments to confirm specificity.
Point Mutation
CRISPR point mutation knock-in introduces specific disease-associated mutations, such as those in KCNJ5, CACNA1D, ATP1A1, and ATP2B3, into adrenal cells to model primary aldosteronism. These models allow researchers to study how mutations alter ion channel function, calcium signaling, and aldosterone secretion, providing insights into the molecular mechanisms of autonomous aldosterone production.
Knock-in
Knock-in of reporter tags (e.g., GFP) or epitope tags into endogenous genes enables visualization and quantification of protein expression in zona glomerulosa cells. Tagged knock-in models can be used to track the localization and dynamics of steroidogenic enzymes like CYP11B2 or ion channels in real time. Additionally, knock-in of human disease variants into mouse models can recapitulate aspects of primary aldosteronism.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression constructs can be used to increase the expression of candidate genes in adrenal cells to test whether they are sufficient to drive aldosterone secretion. Overexpression of genes such as CYP11B2 or mutant ion channels can lead to enhanced aldosterone production, helping to validate their role in the secretion process.
How EDITGENE Supports aldosterone secretion Research
Researchers studying aldosterone secretion-related genes often need to determine whether a candidate gene is causally involved in the regulation of aldosterone production, and whether specific mutations drive autonomous secretion. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions, from generating knockout cell lines to creating precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for aldosterone secretion research.
Frequently Asked Questions About aldosterone secretion
What is aldosterone secretion (GO:0035932)?
Aldosterone secretion is the regulated release of aldosterone, a steroid hormone produced by the zona glomerulosa of the adrenal cortex, into the circulatory system. It acts on the kidney to conserve sodium, secrete potassium, retain water, and increase blood pressure.
What genes are involved in aldosterone secretion?
Key genes include REN, AGT, ACE, AGTR1, CYP11B2, STAR, KCNJ5, CACNA1D, ATP1A1, ATP2B3, and CTNNB1, among others.
How is aldosterone secretion regulated?
It is primarily regulated by the renin-angiotensin-aldosterone system (RAAS), with angiotensin II and potassium as major stimulators. Ion channels and calcium signaling also play critical roles.
What diseases are associated with abnormal aldosterone secretion?
Primary aldosteronism, hypertension, cardiovascular disease, and certain metabolic disorders are associated with dysregulated aldosterone secretion.
What is primary aldosteronism?
Primary aldosteronism is a condition characterized by autonomous aldosterone secretion, leading to hypertension and hypokalemia. It is often caused by adrenal adenomas or hyperplasia.
How can CRISPR be used to study aldosterone secretion?
CRISPR can create knockout, point mutation, knock-in, and overexpression models in adrenal cell lines to study the function of specific genes in aldosterone secretion.
What cell models are used to study aldosterone secretion?
H295R human adrenocortical cells are widely used, along with primary adrenal cells and mouse models. CRISPR-edited versions of these cells allow precise genetic manipulation.
What is autonomous aldosterone secretion?
Autonomous aldosterone secretion refers to aldosterone production that occurs independently of normal regulatory signals, often due to mutations in ion channels or other genes, and is a hallmark of primary aldosteronism.
How is aldosterone secretion measured in the lab?
It is typically measured using ELISA or radioimmunoassay on cell culture supernatants or blood samples. Ion channel activity and calcium signaling can be assessed with patch-clamp and calcium imaging.
Can mathematical models help diagnose aldosterone disorders?
Yes, mathematical models of cyclical aldosterone secretion can improve diagnostic insights for primary hyperaldosteronism by predicting optimal testing times.
Conclusion
Aldosterone secretion (GO:0035932) is a vital biological process that maintains electrolyte balance and blood pressure through the actions of aldosterone on the kidney. Its dysregulation is central to primary aldosteronism, hypertension, and related cardiovascular diseases. Research into the genes, ion channels, and signaling pathways that control aldosterone secretion continues to reveal new therapeutic targets and diagnostic strategies. CRISPR-based models and advanced screening technologies are powerful tools for dissecting the molecular mechanisms of this process and for developing personalized treatments for aldosterone-related disorders.
References
- 1. Te Riet L et al.. 2015. Hypertension: renin-angiotensin-aldosterone system alterations.. Circ Res 116(6):960-75 PMID: 25767283
- 2. Kmieć P et al.. 2022. Autonomous Aldosterone Secretion as a Subclinical Form of Primary Aldosteronism: Pathogenesis and Clinical Significance.. Exp Clin Endocrinol Diabetes 130(1):7-16 PMID: 34614533
- 3. Yang T et al.. 2018. Regulation of aldosterone production by ion channels: From basal secretion to primary aldosteronism.. Biochim Biophys Acta Mol Basis Dis 1864(3):871-881 PMID: 29287775
- 4. Mimouni E et al.. 2025. Predicting Unilateral Aldosterone Secretion in Primary Aldosteronism.. J Surg Res 306:54-61 PMID: 39742658
- 5. Leow MK. 2026. Cyclical aldosterone secretion and diagnostic insights of primary hyperaldosteronism informed by a mathematical model.. Adv Physiol Educ 50(2):584-594 PMID: 41962926
- 6. Komada H et al.. 2020. Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma.. Diabetes Metab 46(3):236-242 PMID: 31676325
- 7. New MI et al.. 1966. Disorders of aldosterone secretion in childhood.. Pediatr Clin North Am 13(1):43-58 PMID: 5324242
- 8. Boyer HG et al.. 2017. Dysregulation of Aldosterone Secretion in Mast Cell-Deficient Mice.. Hypertension 70(6):1256-1263 PMID: 29084882
